SANUWAVE Health, Inc. Accounts Receivable, Allowance for Credit Loss
SANUWAVE Health, Inc. (SNWV) had Accounts Receivable, Allowance for Credit Loss of $1.62 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets
us-gaap:AllowanceForDoubtfulAccountsReceivable · last filed 2026-08-06
- 2026-06-30: Accounts Receivable, Allowance for Credit Loss $1.62M.
- 2026-03-31: Accounts Receivable, Allowance for Credit Loss $1.30M.
- 2025-12-31: Accounts Receivable, Allowance for Credit Loss $1.26M.
- 2025-09-30: Accounts Receivable, Allowance for Credit Loss $1.26M.
| Period end | Accounts Receivable, Allowance for Credit Loss | Accounts Receivable, Allowance for Credit Loss as first filed |
|---|---|---|
| 2026-06-30 | $1.62M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $1.30M 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $1.26M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $1.26M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $1.28M 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $1.18M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $1.15M 10-Q · filed 2026-08-06 | $1.10M 10-K · filed 2025-03-20 |
| 2024-09-30 | $1.06M 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $1.19M 10-Q · filed 2025-08-07 | |
| 2023-12-31 | $1.24M 10-K · filed 2026-03-26 | $1.20M 10-K · filed 2025-03-20 |
| 2022-12-31 | $1.00M 10-K · filed 2025-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |